6 stocks to trim after big runs, plus updates on rest of our portfolio

Jim Cramer and Jeff Marks, the Club’s director of portfolio analysis, ran through all 30 holdings in the portfolio during the June Monthly Meeting on Wednesday. Here’s a rapid fire update on each stock, starting with those that Jim and Jeff said investors should consider trimming — or that the Club has sold recently — as uncertainty over President Donald Trump’s tariffs and the conflict in the Middle East linger. Abbott Laboratories : One of our best stocks of the year, Abbott got more good news Tuesday when HHS chief Robert F. Kennedy Jr. talked up wearable health products. Abbott’s…